A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery

被引:2
|
作者
Aghamiri, Sara Sadat [1 ]
Puniya, Bhanwar Lal [1 ]
Amin, Rada [1 ]
Helikar, Tomas [1 ]
机构
[1] Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
systems immunology; predictive modeling; In-Silico experiments; antigen-presenting cell; dendritic cell; immunology highlights; ACTIVATING RECEPTOR CD226; ANTIGEN-PRESENTING CELLS; DYNAMIC APPROACH; T-CELLS; INNATE; SIGNALS; TUMOR; NEUTROPHILS; PATHWAYS; HMGB1;
D O I
10.3389/fimmu.2023.1112985
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) with the unique ability to mediate inflammatory responses of the immune system. Given the critical role of DCs in shaping immunity, they present an attractive avenue as a therapeutic target to program the immune system and reverse immune disease disorders. To ensure appropriate immune response, DCs utilize intricate and complex molecular and cellular interactions that converge into a seamless phenotype. Computational models open novel frontiers in research by integrating large-scale interaction to interrogate the influence of complex biological behavior across scales. The ability to model large biological networks will likely pave the way to understanding any complex system in more approachable ways. We developed a logical and predictive model of DC function that integrates the heterogeneity of DCs population, APC function, and cell-cell interaction, spanning molecular to population levels. Our logical model consists of 281 components that connect environmental stimuli with various layers of the cell compartments, including the plasma membrane, cytoplasm, and nucleus to represent the dynamic processes within and outside the DC, such as signaling pathways and cell-cell interactions. We also provided three sample use cases to apply the model in the context of studying cell dynamics and disease environments. First, we characterized the DC response to Sars-CoV-2 and influenza co-infection by in-silico experiments and analyzed the activity level of 107 molecules that play a role in this co-infection. The second example presents simulations to predict the crosstalk between DCs and T cells in a cancer microenvironment. Finally, for the third example, we used the Kyoto Encyclopedia of Genes and Genomes enrichment analysis against the model's components to identify 45 diseases and 24 molecular pathways that the DC model can address. This study presents a resource to decode the complex dynamics underlying DC-derived APC communication and provides a platform for researchers to perform in-silico experiments on human DC for vaccine design, drug discovery, and immunotherapies.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] A multiscale mechanistic model of human dendritic cells for in-silico investigation of immune responses and novel therapeutics discovery
    Amin, Rada
    Aghamiri, Sara Sadat
    Puniya, Bhanwar Lal
    Helikar, Tomas
    [J]. JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [2] In-silico Investigation of Ginseng Phytoconstituents as Novel Therapeutics Against MAO-A
    Choudhary, Diksha
    Kaur, Rajwinder
    Rani, Nidhi
    Singh, Thakur Gurjeet
    Kumar, Bhupinder
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (05) : 711 - 722
  • [3] In-silico discovery of novel estrogen receptor-α inhibitors as potential therapeutics for tamoxifen resistant breast cancer
    Singh, Kriti
    Munuganti, Ravi S. N.
    Butler, Miriam
    Cherkasov, Artem
    Rennie, Paul S.
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Toll-like receptor-10 is a novel regulator of immune responses in human plasmacytoid dendritic cells
    Deb, Praik
    Hess, Nicholas James
    Singh, Sukhwinder
    Tapping, Richard
    Fitzgerald-Bocarsly, Patricia
    [J]. CYTOKINE, 2017, 100 : 140 - 140
  • [5] Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1
    Lora Hamuro
    Giridhar S. Tirucherai
    Sean M. Crawford
    Akbar Nayeem
    Renuka C. Pillutla
    Binodh S. DeSilva
    Tarek A. Leil
    Craig J. Thalhauser
    [J]. The AAPS Journal, 21
  • [6] Evaluating a Multiscale Mechanistic Model of the Immune System to Predict Human Immunogenicity for a Biotherapeutic in Phase 1
    Hamuro, Lora
    Tirucherai, Giridhar S.
    Crawford, Sean M.
    Nayeem, Akbar
    Pillutla, Renuka C.
    DeSilva, Binodh S.
    Leil, Tarek A.
    Thalhauser, Craig J.
    [J]. AAPS JOURNAL, 2019, 21 (05):
  • [7] Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis
    Marin, Eros
    Bouchet-Delbos, Laurence
    Renoult, Ophelie
    Louvet, Cedric
    Nerriere-Daguin, Veronique
    Managh, Amy J.
    Even, Amandine
    Giraud, Matthieu
    Thien Phong Vu Manh
    Aguesse, Audrey
    Beriou, Gaelle
    Chiffoleau, Elise
    Alliot-Licht, Brigitte
    Prieur, Xavier
    Croyal, Mikael
    Hutchinson, James A.
    Obermajer, Natasa
    Geissler, Edward K.
    Vanhove, Bernard
    Blancho, Gilles
    Dalod, Marc
    Josien, Regis
    Pecqueur, Claire
    Cuturi, Maria-Cristina
    Moreau, Aurelie
    [J]. CELL METABOLISM, 2019, 30 (06) : 1075 - +
  • [8] Antiviral Immune Responses by Human Langerhans Cells and Dendritic Cells in HIV-1 Infection
    van den Berg, Linda M.
    Geijtenbeek, Teunis B. H.
    [J]. HIV INTERACTIONS WITH DENDRITIC CELLS: INFECTION AND IMMUNITY, 2013, 762 : 45 - 70
  • [9] Dermal dendritic cells distinct from Langerhans cells are capable of initiating human immune responses
    Angel, CE
    George, E
    Brooks, AES
    Ostrovsky, LL
    Brown, TLH
    Dunbar, PR
    [J]. TISSUE ANTIGENS, 2005, 66 (05): : 350 - 350
  • [10] Phagocytosis of Enterovirus-Infected Pancreatic β-Cells Triggers Innate Immune Responses in Human Dendritic Cells
    Schulte, Barbara M.
    Kramer, Matthijs
    Ansems, Marleen
    Lanke, Kjerstin H. W.
    van Doremalen, Neeltje
    Piganelli, Jon D.
    Bottino, Rita
    Trucco, Massimo
    Galama, Jochem M. D.
    Adema, Gosse J.
    van Kuppeveld, Frank J. M.
    [J]. DIABETES, 2010, 59 (05) : 1182 - 1191